Difficult illnesses such as relapsing chronic skin disease, a global health problem causes an immense amount of physical, mental & emotional disabilities. As per the British Association of Dermatologists, 85% of skin disease suffering gets impacted by psychosocial challenges & dysfunction causing a lot of mental discomfort.
Through psycho neuro-immuno-endocrine & behavioural mechanisms, skin disorders affect the body’s psychological makeup, lowers self control, increases distorted thought processes, affects self esteem, and lower the quality of life.
Provokes fearful anticipation developments, depressive symptoms & reduces psychological well being interest.
Increases psycho-traumatic nature, shamefulness, worthlessness, embarrassment, chances of getting bullied, irritability & short-temperateness. Also reinforces depression, anxiety, social avoidance and loneliness.
Makes patients feel anxious, frustrated with doctors & family members. Increases eagerness to find remedies at any cost. Reduces work productivity, enhances absenteeism from work & expenditure on alternative medicine practitioners, inauthentic treatment methods and advice. Simultaneously initiates sleep disturbances & negatively affects work life balance.
Induces chances of social isolation, loneliness, disturbed quality of life & overall health. Continuous scratching & flaky skin physical appearance ignites depressive, embarrassment, secretiveness, & helpless, stigmatized feelings.
Significantly affects leisure activities, housework & going out for socializing.
Generates shame, depression, anxiety and inferiority complex and attempting to hide hair loss with wigs & hats.
It should include disease related theoretical & practical data & interventions provided by the doctors & caregivers.
Appropriate validation of patient concern right from initial diagnosis of skin disorder.
Availability of correct scientifically driven disease related medical & non medical information, query solving, dissolving misconceptions.
Usage of emollients, creams, and oral medications for management of skin pathology & psychotropic medications to address comorbid psychiatric illnesses.
Creating awareness about the ill effects of stress on skin disease progression & providing simple stress management techniques.
Altering the underlying cognition & understanding the dysfunctional thought processes.
Acceptance and commitment therapy (ACT):
Changing the patient's relationship with their symptoms & strengthening psychological flexibility.
Adding meditation, exercise, and yoga to encourage living in present reality and discouraging strong bonds towards emotional beliefs which causes emotional imbalance and disrupts well-being.
Giving neutral action therapies like awareness training, competing response & positive continuous motivation.
Proactively initiating disease related education, its impact on life & prioritizing various therapeutic options.
Medical fraternity & patient caregivers should always be inquisitive to find, assess & screen mental health disturbances in patients. Simultaneously the patient's detailed orientation regarding skin disease & mental health disturbances should be a part of pre & post routine dermatological interventions.
1.
Stem Cell Selection Unneeded for SSc Transplant Therapy?
2.
Lung Transplant for Lung Cancer: Promising, in Rare Cases
3.
Rural-urban disparities seen in cervical cancer
4.
Obesity linked to subsequent neoplasms in childhood cancer survivors
5.
New policy review highlights the importance of health-related quality of life in advanced cancer
1.
Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights
2.
Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care
3.
Is AI The New Radiologist For Breast MRI?
4.
Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies
5.
Bone Marrow Regeneration in Hematologic Recovery
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part VI
2.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation